-
Je něco špatně v tomto záznamu ?
Effects of body fat reduction on plasma adipocyte fatty acid-binding protein concentration in obese patients with type 1 diabetes mellitus
V. Blaha, F. Musil, A. Smahelova, A. Ticha, R. Hyspler, M. Haluzik, J. Lesna, L. Sobotka,
Jazyk angličtina Země Švédsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT12287
MZ0
CEP - Centrální evidence projektů
- MeSH
- diabetes mellitus 1. typu farmakoterapie metabolismus MeSH
- dospělí MeSH
- glykemický clamp MeSH
- hmotnostní úbytek fyziologie MeSH
- hypoglykemika aplikace a dávkování MeSH
- inzulin aplikace a dávkování MeSH
- inzulinová rezistence fyziologie MeSH
- kyseliny mastné neesterifikované krev MeSH
- lidé středního věku MeSH
- lidé MeSH
- obezita dietoterapie metabolismus MeSH
- omezení příjmu potravy fyziologie MeSH
- proteiny vázající mastné kyseliny krev MeSH
- redukční dieta MeSH
- složení těla fyziologie MeSH
- tuková tkáň metabolismus MeSH
- tukové buňky metabolismus MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVES: The influence of body fat reduction on adipocyte fatty acid-binding protein (A-FABP) in obese patients with type 1 diabetes mellitus (T1DM) was investigated to examine whether it relates to the etiopathogenesis of insulin resistance (IR) and obesity. METHODS: We studied 14 obese patients with T1DM and IR (42.6±9.4 years, BMI 32.4±2.1 kg/m2) and 13 non-obese control patients with T1DM (36.9±13.9 years, BMI 22.6±2.1 kg/m2). Plasma FABP was measured by ELISA and plasma free fatty acids (FFA) were measured spectrophotometrically before weight reduction, immediately after 7 days of fasting and after 21 days on a low-calorie diet. The control group was studied only after overnight fasting. Body composition was examined using bioimpedance spectroscopy. The means ± SD, T-test, one-way ANOVA and Spearman's correlation were used for statistical evaluation. RESULTS: All patients tolerated the period of fasting. Obese T1DM patients lost 6.1±1.1 kg. There was a significant decrease in body mass index and body fat measured 21 days after weight reduction (p<0.05). Plasma FABP and FFA concentrations in obese T1DM patients before weight reduction were significantly higher than in controls, further increased significantly after fasting (p<0.05) and were restored thereafter. Significant positive correlations between FABP and FFA and between FABP and BMI (p<0.05) were found. CONCLUSION: Increased plasma FABP indicates insulin resistance in obese patients with T1DM. Weight reduction in T1DM patients is associated with a desirable decrease of body fat and transiently increased FABP. This increase might be a temporary adaptation of metabolism to non-stress fasting.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13024118
- 003
- CZ-PrNML
- 005
- 20190816085637.0
- 007
- ta
- 008
- 130703s2012 sw f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)23183502
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Bláha, Vladimír, $u 3rd Department of Medicine, Metabolic Care and Gerontology, Charles University in Hradec Králové, Czech Republic $d 1964- $7 xx0002944
- 245 10
- $a Effects of body fat reduction on plasma adipocyte fatty acid-binding protein concentration in obese patients with type 1 diabetes mellitus / $c V. Blaha, F. Musil, A. Smahelova, A. Ticha, R. Hyspler, M. Haluzik, J. Lesna, L. Sobotka,
- 520 9_
- $a OBJECTIVES: The influence of body fat reduction on adipocyte fatty acid-binding protein (A-FABP) in obese patients with type 1 diabetes mellitus (T1DM) was investigated to examine whether it relates to the etiopathogenesis of insulin resistance (IR) and obesity. METHODS: We studied 14 obese patients with T1DM and IR (42.6±9.4 years, BMI 32.4±2.1 kg/m2) and 13 non-obese control patients with T1DM (36.9±13.9 years, BMI 22.6±2.1 kg/m2). Plasma FABP was measured by ELISA and plasma free fatty acids (FFA) were measured spectrophotometrically before weight reduction, immediately after 7 days of fasting and after 21 days on a low-calorie diet. The control group was studied only after overnight fasting. Body composition was examined using bioimpedance spectroscopy. The means ± SD, T-test, one-way ANOVA and Spearman's correlation were used for statistical evaluation. RESULTS: All patients tolerated the period of fasting. Obese T1DM patients lost 6.1±1.1 kg. There was a significant decrease in body mass index and body fat measured 21 days after weight reduction (p<0.05). Plasma FABP and FFA concentrations in obese T1DM patients before weight reduction were significantly higher than in controls, further increased significantly after fasting (p<0.05) and were restored thereafter. Significant positive correlations between FABP and FFA and between FABP and BMI (p<0.05) were found. CONCLUSION: Increased plasma FABP indicates insulin resistance in obese patients with T1DM. Weight reduction in T1DM patients is associated with a desirable decrease of body fat and transiently increased FABP. This increase might be a temporary adaptation of metabolism to non-stress fasting.
- 650 _2
- $a tukové buňky $x metabolismus $7 D017667
- 650 _2
- $a tuková tkáň $x metabolismus $7 D000273
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a složení těla $x fyziologie $7 D001823
- 650 _2
- $a diabetes mellitus 1. typu $x farmakoterapie $x metabolismus $7 D003922
- 650 _2
- $a redukční dieta $7 D004038
- 650 _2
- $a omezení příjmu potravy $x fyziologie $7 D005215
- 650 _2
- $a proteiny vázající mastné kyseliny $x krev $7 D050556
- 650 _2
- $a kyseliny mastné neesterifikované $x krev $7 D005230
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a glykemický clamp $7 D015309
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypoglykemika $x aplikace a dávkování $7 D007004
- 650 _2
- $a inzulin $x aplikace a dávkování $7 D007328
- 650 _2
- $a inzulinová rezistence $x fyziologie $7 D007333
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a obezita $x dietoterapie $x metabolismus $7 D009765
- 650 _2
- $a hmotnostní úbytek $x fyziologie $7 D015431
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Musil, František, $u 3rd Department of Medicine, Metabolic Care and Gerontology, Charles University in Hradec Králové, Czech Republic $d 1974- $7 xx0076218
- 700 1_
- $a Šmahelová, Alena, $u 3rd Department of Medicine, Metabolic Care and Gerontology, Charles University in Hradec Králové, Czech Republic $d 1952- $7 skuk0001359
- 700 1_
- $a Tichá, Alena, $u 3rd Department of Medicine, Metabolic Care and Gerontology, Charles University in Hradec Králové, Czech Republic $d 1976- $7 xx0076494
- 700 1_
- $a Hyšpler, Radomír, $u 3rd Department of Medicine, Metabolic Care and Gerontology, Charles University in Hradec Králové, Czech Republic $d 1972- $7 nlk20040155091
- 700 1_
- $a Haluzík, Martin, $u 3rd Department of Medicine, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $d 1970- $7 xx0000707
- 700 1_
- $a Förstlová, Jana $u 3rd Department of Medicine, Metabolic Care and Gerontology, Charles University in Hradec Králové, Czech Republic $7 xx0211829
- 700 1_
- $a Sobotka, Luboš, $u 3rd Department of Medicine, Metabolic Care and Gerontology, Charles University in Hradec Králové, Czech Republic $d 1952- $7 jn20001005317
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 33 Suppl 2(2012), s. 6-12
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23183502 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130703 $b ABA008
- 991 __
- $a 20190816085906 $b ABA008
- 999 __
- $a ok $b bmc $g 987798 $s 822498
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 33 Suppl 2 $d 6-12 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- GRA __
- $a NT12287 $p MZ0
- LZP __
- $a Pubmed-20130703